FTC sues major pharmacy profit supervisors about insulin price ranges The agency brought action from Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating procedures “artificially inflated” the checklist cost of existence-preserving insulin medicine. Before this summer months, the organization held prolonged negotiations with Steward around ways https://edgaruslbr.blogtov.com/11141299/the-smart-trick-of-healthcare-news-that-no-one-is-discussing